Marko Hyvönen
University of Cambridge
H-index: 37
Europe-United Kingdom
Top articles of Marko Hyvönen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
CK2 Inhibitors Targeting Inside and Outside the Catalytic Box | Sophie Day-Riley Rebekah M West Paul D Brear Marko Hyvönen David R Spring | 2024/3/26 | |
O148: Unlocking Enhanced Immunity in Pancreatic Ductal Adenocarcinoma: Activins Interplay with CAF-Stroma Mechanisms | British Journal of Surgery | Simon McCluney Danielle Park Daniel Miller Robert Bloxham Merima Mehic | 2024/3 |
Benzo [c][2, 6] naphthyridine derivatives, compositions and therapeutic uses thereof | 2024/1/9 | ||
A versatile Halo-and SNAP-tagged BMP/TGFβ receptor library for quantification of cell surface ligand binding | Communications Biology | Jerome Jatzlau Wiktor Burdzinski Michael Trumpp Leon Obendorf Kilian Roßmann | 2023/1/12 |
Selective Aurora A-TPX2 interaction inhibitors have in vivo efficacy as targeted anti-mitotic agents | Simon R Stockwell Duncan E Scott Gerhard Fischer Estrella Guarino Timothy PC | 2023/3/22 | |
SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing … | Scientific Reports | Victor Bolsanelli Cioffi Maria Fernanda de Castro-Amarante Aleksei Lulla Robert Andreata-Santos Mario Costa Cruz | 2023/10/5 |
Cover Feature: Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase (ChemBioChem 1/2023) | ChemBioChem | Umberto Maria Battisti Chunxia Gao Oscar Nilsson Fady Akladios Aleksei Lulla | 2023/1/3 |
Selective inhibitors of the Aurora A-TPX2 protein-protein interaction exhibit in vivo efficacy as targeted anti-mitotic agents | Simon R Stockwell Duncan E Scott Gerhard Fischer Estrella Guarino Timothy PC | 2023/3/22 | |
Development of isoselenazolium chlorides as selective pyruvate kinase isoform M2 inhibitors | European Journal of Medicinal Chemistry | Pavels Dimitrijevs Marina Makrecka-Kuka Agnieszka Bogucka Marko Hyvönen Teodors Pantelejevs | 2023/9/5 |
Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase | ChemBioChem | Umberto Maria Battisti Chunxia Gao Oscar Nilsson Fady Akladios Aleksei Lulla | 2023/1/3 |
Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators | European Journal of Medicinal Chemistry | Amalyn Nain-Perez Oscar Nilsson Aleksei Lulla Liliana Håversen Paul Brear | 2023/3/15 |
Structure-Guided Chemical Optimization of Bicyclic Peptide (Bicycle) Inhibitors of Angiotensin-Converting Enzyme 2 | Journal of Medicinal Chemistry | Maximilian AJ Harman Steven J Stanway Heather Scott Yuliya Demydchuk Gustavo Arruda Bezerra | 2023/7/11 |
Profiling human hypothalamic neurons reveals a candidate combination drug therapy for weight loss | bioRxiv | Hsiao-Jou Cortina Chen Andrian Yang Simone Mazzaferro Iman Mali Olivier Cahn | 2023 |
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade | Nature Communications | Juan Carlos Yam-Puc Zhaleh Hosseini Emily C Horner Pehuén Pereyra Gerber Nonantzin Beristain-Covarrubias | 2023/6/27 |
Evolution of protease activation and specificity via alpha-2-macroglobulin-mediated covalent capture | Nature Communications | Philipp Knyphausen Mariana Rangel Pereira Paul Brear Marko Hyvönen Lutz Jermutus | 2023/2/11 |
A recombinant approach for stapled peptide discovery yields inhibitors of the RAD51 recombinase | Chemical Science | Teodors Pantelejevs Pedro Zuazua-Villar Oliwia Koczy Andrew J Counsell Stephen J Walsh | 2023 |
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2 | Nature communications | Katherine U Gaynor Marina Vaysburd Maximilian AJ Harman Anna Albecka Phillip Jeffrey | 2023/6/16 |
Microfluidics-enabled fluorescence-activated cell sorting of single pathogen-specific antibody secreting cells for the rapid discovery of monoclonal antibodies | bioRxiv | Katrin Fischer Aleksei Lulla Tsz So Pehuen Pereyra-Gerber Matthew IJ Raybould | 2023 |
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors | Nature Chemical Biology | Maria Reinecke Paul Brear Larsen Vornholz Benedict-Tilmann Berger Florian Seefried | 2023/10/30 |
Development of small cyclic peptides targeting the CK2α/β interface | Chemical Communications | Eleanor L Atkinson Jessica Iegre Claudio D’Amore Paul Brear Mauro Salvi | 2022 |
Co-Authors
